116
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

Long term survivor of MOZ-p300 therapy-related acute myeloid leukemia after matched unrelated donor bone marrow transplantation

, , , , &
Pages 1344-1347 | Received 02 Jan 2023, Accepted 11 Apr 2023, Published online: 20 Apr 2023

References

  • Bhatia S. Therapy-related myelodysplasia and acute myeloid leukemia. Semin Oncol. 2013;40(6):666–675.
  • Sharma A, Huang S, Li Y, et al. Outcomes of pediatric patients with therapy-related myeloid neoplasms. Bone Marrow Transplant. 2021;56(12):2997–3007.
  • Katsumoto T, Ogawara Y, Yamagata K, et al. MOZ is critical for the development of MOZ/MLL fusion-induced leukemia through regulation of Hoxa9/Meis1 expression. Blood Adv. 2022;6(19):5527–5537.
  • Borrow J, Stanton VPJr, Andresen JM, et al. The translocation t(8;16)(p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB-binding protein. Nat Genet. 1996;14(1):33–41.
  • Chaffanet M, Gressin L, Preudhomme C, et al. MOZ is fused to p300 in an acute monocytic leukemia with t(8;22). Genes Chromosom Cancer. 2000;28(2):138–144.
  • Kitabayashi I, Aikawa Y, Yokoyama A, et al. Fusion of MOZ and p300 histone acetyltransferases in acute monocytic leukemia with a t(8;22)(p11;q13) chromosome translocation. Leukemia. 2001;15(1):89–94.
  • Lai JL, Zandecki M, Fenaux P, et al. Acute monocytic leukemia with (8;22)(p11;q13) translocation. Involvement of 8p11 as in classical t(8;16)(p11;p13). Cancer Genet Cytogenet. 1992;60(2):180–182.
  • Soenen V, Chaffanet M, Preudhomme C, et al. Identification of a YAC spanning the translocation breakpoint t(8;22) associated with acute monocytic leukemia. Genes Chromosom Cancer. 1996;15(3):191–194.
  • Coenen EA, Zwaan CM, Reinhardt D, et al. Pediatric acute myeloid leukemia with t(8;16)(p11;p13), a distinct clinical and biological entity: a collaborative study by the International-Berlin-Frankfurt-Munster AML-study group. Blood. 2013;122(15):2704–2713.
  • Haferlach T, Kohlmann A, Klein HU, et al. AML with translocation t(8;16)(p11;p13) demonstrates unique cytomorphological, cytogenetic, molecular and prognostic features. Leukemia. 2009;23(5):934–943.
  • Gervais C, Murati A, Helias C, et al. Acute myeloid leukaemia with 8p11 (MYST3) rearrangement: an integrated cytologic, cytogenetic and molecular study by the groupe francophone de cytogénétique hématologique. Leukemia. 2008;22(8):1567–1575.
  • Patnaik MM, Gangat N, Knudson RA, et al. Chromosome 8p11.2 translocations: prevalence, FISH analysis for FGFR1 and MYST3, and clinicopathologic correlates in a consecutive cohort of 13 cases from a single institution. Am J Hematol. 2010;85(4):238–242.
  • Ikawa Y, Nishimura R, Maeba H, et al. Deep spontaneous molecular remission in a patient with congenital acute myeloid leukemia expressing a novel MOZ-p300 fusion transcript. Leuk Lymphoma. 2018;59(10):2497–2499.
  • Imataki O, Uemura M. Sea-blue histiocytosis of bone marrow in a patient with t(8;22) acute myeloid leukemia. Case Rep Oncol. 2020;13(2):849–852.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.